BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20564865)

  • 21. SGO White Paper on ovarian cancer: etiology, screening and surveillance.
    Schorge JO; Modesitt SC; Coleman RL; Cohn DE; Kauff ND; Duska LR; Herzog TJ
    Gynecol Oncol; 2010 Oct; 119(1):7-17. PubMed ID: 20692025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.
    Andersen MR; Peacock S; Nelson J; Wilson S; McIntosh M; Drescher C; Urban N
    Gynecol Oncol; 2002 Apr; 85(1):3-8. PubMed ID: 11925113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
    Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for ovarian cancer: what we know, what we need to know.
    Hensley ML; Castiel M; Robson ME
    Oncology (Williston Park); 2000 Nov; 14(11):1601-7; discussion 1608, 1613-6. PubMed ID: 11125943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
    Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
    Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ovarian cancer screening in the general population].
    Mathevet P; Delaloye JF
    Rev Med Suisse; 2013 Oct; 9(403):1943-4, 1946-9. PubMed ID: 24245016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer screening.
    Neesham D
    Aust Fam Physician; 2007 Mar; 36(3):126-8. PubMed ID: 17339973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):557-71. PubMed ID: 1810100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.
    Kim PS; Djazayeri S; Zeineldin R
    Gynecol Oncol; 2011 Mar; 120(3):393-403. PubMed ID: 21168905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal biomarkers in the early detection of ovarian cancer.
    Galea M; Gauci G; Calleja-Agius J; Schembri-Wismayer P
    Minerva Ginecol; 2017 Feb; 69(1):84-99. PubMed ID: 27284942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for early ovarian cancer.
    Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
    Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is ultrasound screening for ovarian cancer possible in 1998?].
    Descamps P; Fondrinier E; Biquard F; Binelli C; Lepinard C; Loisel D; Crvencowitcz G; Platt LD; Karlan BY
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):476-81. PubMed ID: 9791573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening program in ovarian cancer: A logical step in clinical management? A meta-analysis.
    Marchetti C; De Felice F; Perniola G; Lecce F; Vertechy L; Monti M; Musio D; Muzii L; Tombolini V; Benedetti Panici P
    Curr Probl Cancer; 2018; 42(2):235-240. PubMed ID: 29433824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound screening in women at risk for ovarian cancer.
    Andolf E
    Clin Obstet Gynecol; 1993 Jun; 36(2):423-32. PubMed ID: 8513636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening of ovarian cancer : not for tomorrow].
    Vuilleumier A; Labidi-Galy I
    Rev Med Suisse; 2017 May; 13(563):1039-1041. PubMed ID: 28636295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of ovarian cancer: a 75-year-old woman who has completed treatment.
    Konstantinopoulos PA; Awtrey CS
    JAMA; 2012 Apr; 307(13):1420-9. PubMed ID: 22396438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.